General MedicationsORALStandard
ABACAVIR SULFATE
ABACAVIR SULFATE
Standard Dose
EQ 20MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ABACAVIR SULFATE is listed in Drugs@FDA under application 201107 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ABACAVIR SULFATE Form and strength SOLUTION;ORAL - EQ 20MG BASE/ML Sponsor HETERO LABS LTD III Submission history Latest submission status date: 2019-12-13 00:00:00.
Structured Monograph
Clinical summary
Approval overview ABACAVIR SULFATE is listed in Drugs@FDA under application 201107 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ABACAVIR SULFATE Form and strength SOLUTION;ORAL - EQ 20MG BASE/ML Sponsor HETERO LABS LTD III Submission history Latest submission status date: 2019-12-13 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.